Evidence map›Paper›PMID 42755741›Full record

ArticleFrontiers in endocrinology2026

Plasma copeptin is coupled to resting-state frontoinsular-subgenual alpha dynamics in major depression with comorbid post-traumatic stress disorder.

Hiroe Hu, Benjamin H Chandler, Jessica L Sloane, Joseph G Verbalis, Carlos A Zarate, Elizabeth D Ballard, Jessica R Gilbert

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hiroe HuExperimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States.
Benjamin H ChandlerExperimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States.
Jessica L SloaneExperimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States.
Joseph G VerbalisDepartment of Endocrinology, Georgetown University, Washington, DC, United States.
Carlos A ZarateExperimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States.
Elizabeth D BallardExperimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States.
Jessica R GilbertExperimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States.

Funding

Target validation of novel therapeutic agents in mood disordersZIAMH002927 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI ZARATE, CARLOS · 2010 to 2025
$37.1M
Intramural NIH HHS ZIA MH002927
6 · The paper itself

Abstract

Background: Hypothalamic-pituitary-adrenal axis dysregulation is implicated in depression and post-traumatic stress disorder (PTSD), but stress-related neuroendocrine mechanisms that distinguish their comorbid presentation remain poorly understood. Prior work in the broader parent cohort found lower levels of plasma copeptin, a surrogate marker of arginine vasopressin, in 0individuals experiencing a major depressive episode (MDE) who also had PTSD. The present study examined whether copeptin was associated with frequency-specific resting-state neural activity and circuit dynamics in an overlapping magnetoencephalography (MEG) subset of participants with MDE+PTSD, MDE without PTSD, and healthy volunteers (HVs). Methods: Whole blood samples were collected from 105 participants (MDE+PTSD=18, MDE=59, HV=28) and assayed for plasma copeptin concentrations. Eyes-closed resting-state MEG data were acquired and source localized using synthetic aperture magnetometry in the delta, theta, alpha, beta, gamma, and high gamma frequency bands. Linear mixed models were used to examine copeptin-by-diagnosis interactions in whole-brain source-localized power. Two regions of interest implicated in affective, interoceptive, and stress-related processing-the left anterior insula (AI) and subgenual anterior cingulate cortex (sgACC)-were further examined using virtual electrodes and dynamic causal modeling. Parametric empirical Bayesian analysis modeled group differences with mean-centered copeptin values entered as covariates. Results: In the alpha frequency band, a significant group-by-copeptin interaction (pCLC<0.05) was identified in medial and lateral prefrontal cortex, including the sgACC and AI. Compared with the HV and MDE groups, MDE+PTSD participants demonstrated a negative association between alpha power and copeptin levels. In the high gamma band, a significant main effect of diagnosis was identified in early visual cortex, encompassing the bilateral lingual gyrus, with both clinical groups showing greater power than HVs. Dynamic causal modeling of sgACC-AI circuitry showed strong evidence (Pp>0.99) for reduced intrinsic excitatory drive within the sgACC and AI in the MDE+PTSD group. Higher copeptin levels in the comorbid group were associated with local circuit changes consistent with reduced excitatory throughput and faster inhibitory timing. Conclusion: These findings raise the possibility that MDE+PTSD may represent a distinct neuroendocrine-neurophysiologic phenotype in which the relationship between peripheral vasopressinergic signaling and cortical alpha dynamics/frontoinsular-subgenual circuit function is altered.

Indexed as

GlycopeptidesInsular CortexMajor Depressive DisorderStress Disorders, Post-TraumaticAdultBiomarkersComorbidityFemaleHumansMagnetoencephalographyMaleMiddle AgedRestYoung AdultBiomarkerscopeptinsGlycopeptidesanterior insulacopeptindepressionmagnetoencephalographyPTSDsgACCvasopressin

Identifiers

PMID42755741
PMCPMC13581851

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.